Technical Analysis for AVTE - Aerovate Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
20 DMA Support | Bullish | -6.12% | |
Pocket Pivot | Bullish Swing Setup | -6.12% | |
Bollinger Band Squeeze | Range Contraction | -6.12% | |
Up 3 Days in a Row | Strength | -6.12% | |
Slingshot Bearish | Bearish Swing Setup | -2.09% | |
Crossed Above 20 DMA | Bullish | -2.09% | |
MACD Bullish Signal Line Cross | Bullish | -2.09% | |
Stochastic Buy Signal | Bullish | -2.09% |
Alert | Time |
---|---|
Fell Below 10 DMA | 2 days ago |
10 DMA Support | 2 days ago |
Down 5% | 2 days ago |
Fell Below Previous Day's Low | 2 days ago |
Fell Below 20 DMA | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 32.415 |
52 Week Low | 9.41 |
Average Volume | 176,429 |
200-Day Moving Average | 18.28 |
50-Day Moving Average | 24.08 |
20-Day Moving Average | 20.89 |
10-Day Moving Average | 20.54 |
Average True Range | 1.75 |
RSI (14) | 44.75 |
ADX | 13.93 |
+DI | 21.91 |
-DI | 19.27 |
Chandelier Exit (Long, 3 ATRs) | 18.72 |
Chandelier Exit (Short, 3 ATRs) | 23.63 |
Upper Bollinger Bands | 22.80 |
Lower Bollinger Band | 18.97 |
Percent B (%b) | 0.42 |
BandWidth | 18.33 |
MACD Line | -0.90 |
MACD Signal Line | -1.09 |
MACD Histogram | 0.1947 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 23.03 | ||||
Resistance 3 (R3) | 23.20 | 22.55 | 22.62 | ||
Resistance 2 (R2) | 22.55 | 21.92 | 22.47 | 22.48 | |
Resistance 1 (R1) | 21.56 | 21.54 | 21.24 | 21.39 | 22.35 |
Pivot Point | 20.91 | 20.91 | 20.75 | 20.83 | 20.91 |
Support 1 (S1) | 19.92 | 20.28 | 19.60 | 19.75 | 18.79 |
Support 2 (S2) | 19.27 | 19.90 | 19.19 | 18.66 | |
Support 3 (S3) | 18.28 | 19.27 | 18.52 | ||
Support 4 (S4) | 18.11 |